Projecting Long-term Health and Economic Burden of COPD in the United States

Keyphrases

• United States 100%
• Long-term Health 100%
• Economic Burden 100%
• Quality-adjusted Life Years 100%
• Health Burden 100%
• Quality Loss 100%
• Absenteeism Costs 100%
• Direct Medical Costs 66%
• Disease Burden 66%
• Population Growth 66%
• Smoking Status 33%
• Direct Costs 33%
• American Society 33%
• Treatment Efficacy 33%
• Prevalence Rate 33%
• Monte Carlo Simulation 33%
• Number of Deaths 33%
• Male Subjects 33%
• Smoking Prevalence 33%
• Substantial Burden 33%
• Female Subjects 33%
• Causes of Mortality 33%
• Credible Interval 33%
• Markov Model 33%
• Loss Cost 33%
• Current Pattern 33%
• Cost-effective Intervention 33%
• Continued Smoking 33%
• Severity Grading 33%
• Societal Health 33%
• Publicly Available Dataset 33%
• COPD Prevalence 33%

Biochemistry, Genetics and Molecular Biology

• Quality Adjusted Life Year 100%
• Disease Burden 66%
• Population Growth 66%
• Prevalence 33%